Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.6 USD | +3.02% | +1.10% | +0.66% |
05-10 | Edesa Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
03-05 | Top Premarket Gainers | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
14.36M | - | - | - | - | - | |
116B | ||||||
106B | ||||||
23.89B | - | |||||
21.58B | - | |||||
18.96B |
- Stock Market
- Equities
- EDSA Stock
- Charts Edesa Biotech, Inc.
- Sector Chart